Drug intelligence / Profile preview

Lumixa

Development stage
Unknown
Lead developer
FB Dermatology
Modality
Hydrogel Systems → Drug Delivery Systems, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Lumixa is a professional phototherapy system that utilizes Fluorescent Light Energy (FLE) to treat various skin conditions and signs of aging. It consists of a topical, non-absorbing gel containing patented exogenous chromophores (such as Fluorophyll N, Fluorocumin C, and Fluorospir) that act as photoconverters. When applied to the skin and activated by a specific LED light source, these chromophores absorb photons and re-emit a dynamic spectrum of hyperpulsed, polychromatic fluorescent light across multiple wavelengths. This energy penetrates the epidermal and dermal layers to induce photobiomodulation, which stimulates mitochondrial activity, increases ATP production, and modulates cellular signaling in fibroblasts and keratinocytes. Lumixa is primarily used to address 'inflammageing', reduce fine lines and wrinkles, and stimulate collagen production without causing thermal damage or downtime.

Brand names
LumixaLumixa Skin NormaliserLumixa Collagen BoosterLumixa Age Control
Other names
Lumixa FLEFluorejuvenationFLETECH
02

Targets

COX7A1 (Cytochrome C Oxidase)FGFs (FGF ligand family)

Beyond the preview

Go deeper on Lumixa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lumixa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call